Overall impact
C (57)

Commentary

Braskem is an average overall performer. With a 'C' rating of 57.0 for overall impact (56th percentile compared to all companies), Braskem ranks 38th out of 151 industry peers, behind Northern Technologies International, Gulf Resources, Ingevity and 34 others, and ahead of Amyris, Aemetis, Kraton and 110 others. On top material causes for Braskem's industry (Chemicals), Braskem performs well in Sanitation Access (90.2 score), Fair Labor Practices (95.6), Improved Mental Health (87.1) and 4 other causes where it received an 'A' score and performs poorly in Child and Maternal Health (24.4 score), Accountable Institutions (38.5), Sustainable Use of Natural Resources (8.6) and 2 other causes where it received a 'D' or 'F' score.
Screens
Advertising
Alcohol
Alcohol - responsible marketing
Animal treatment
Anti-abortion support
Anti-personnel mines
Antisemitism
Arctic drilling
Banned pesticides and chemicals
Biological and chemical weapons
Cannabis
Carbon emissions intensity
Child safety
Cluster munitions
Coal
Contraceptives
Controversial weapons
Deforestation - financing
Depleted uranium
Discrimination controversies
Electrical utility
Endangered wildlife
Environmental controversies
EU sanctions list
Factory farming
Fast food
Firearms
Food commodity derivatives
For-profit health care
Fossil fuel
Fur
Gambling
Genetic engineering
Health-related controversies
Human rights controversies
Human trafficking
ILO Conventions
Interest-based products
Interest-bearing debt
Interest-bearing securities
Iran
Land use and biodiversity
Military contracting
Misleading communication
Music
Myanmar
Non-sustainable palm oil
Norges Bank exclusion list
Northern Ireland (Macbride)
North Korea
No SBTI commitment
Nuclear
OECD Guidelines
Oil and gas
Opioid controversies
Oppressive governments
Palestinian human rights
Pharma controversies
Pork
Pornography
Predatory lending
Prison involvement
Privacy breaches
Pro-life
Russia
Single-use plastic
Stem cell research
Sudan
Sugar
Syria
Tar sands
Thermal coal
Tobacco
Tobacco - GICS
UK sanctions list
Undermining US elections
UN Global Compact
UN Guiding Principles
US OFAC sanctions list
Weapons
Impact
Cause BAK
Peer rank
Overall impact

Log in to view this information

Screens
Advertising
Alcohol
Alcohol - responsible marketing
Animal treatment
Anti-abortion support
Anti-personnel mines
Antisemitism
Arctic drilling
Banned pesticides and chemicals
Biological and chemical weapons
Cannabis
Carbon emissions intensity
Child safety
Cluster munitions
Coal
Contraceptives
Controversial weapons
Deforestation - financing
Depleted uranium
Discrimination controversies
Electrical utility
Endangered wildlife
Environmental controversies
EU sanctions list
Factory farming
Fast food
Firearms
Food commodity derivatives
For-profit health care
Fossil fuel
Fur
Gambling
Genetic engineering
Health-related controversies
Human rights controversies
Human trafficking
ILO Conventions
Interest-based products
Interest-bearing debt
Interest-bearing securities
Iran
Land use and biodiversity
Military contracting
Misleading communication
Music
Myanmar
Non-sustainable palm oil
Norges Bank exclusion list
Northern Ireland (Macbride)
North Korea
No SBTI commitment
Nuclear
OECD Guidelines
Oil and gas
Opioid controversies
Oppressive governments
Palestinian human rights
Pharma controversies
Pork
Pornography
Predatory lending
Prison involvement
Privacy breaches
Pro-life
Russia
Single-use plastic
Stem cell research
Sudan
Sugar
Syria
Tar sands
Thermal coal
Tobacco
Tobacco - GICS
UK sanctions list
Undermining US elections
UN Global Compact
UN Guiding Principles
US OFAC sanctions list
Weapons
Impact trend

Change in rating for overall impact

Log in to view this information

BAK Price
$4.82
Last available end-of-day price. Full disclosure
Revenue
$12.31 billion
Market cap
$2.22 billion
Public/private
Public
Hypothetical historical growth of $10,000
Historical performance
Company
Employees
8,569
Sector
Materials
Industry
Chemicals
Sub-industry
Specialty Chemicals
SASB industry
Chemicals
Headquarters
Sp, Brazil
Share classes
BAK
BRD
ADR
Description
Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; intermediates, such as cumene, paraxylene, ortho-xylene, and others; polyethylene (PE) and polypropylene (PP); polyvinyl chloride; hydrochloric acid, dichloroethane " EDC, and sodium hypochlorite; fuels, such as gasoline, boosters, and others; solvents, such as toluene, xylene, and other products; and specialties comprising polyisobutene, hydrocarbon resin, isoprene, dicyclopentadiene, piperylene, nonene, tetramer, green PE wax, and other products. It also supplies electricity and other inputs to second-generation producers; produces and sells caustic soda; produces and sells ethylene, high-density PE, and low-density PE in Mexico; manufactures, sells, imports, and exports chemicals, petrochemicals, and fuels; and produces, supplies, and sells utilities, such as steam, water, compressed air, and industrial gases. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is headquartered in São Paulo, Brazil. Braskem S.A. operates as a subsidiary of Novonor S.A.
Material causes
Ethos considers the following causes material for Braskem, based on its industry sub-industry Specialty Chemicals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.